Penicillin Allergy Evaluation Access: A National Survey

Christian M Mancini; Xiaoqing Fu; Yuqing Zhang; Kristi Kuper; Lucas T Schulz; Tanaya Bhowmick; Michael Postelnick; Francesca Lee; Rochelle P Walensky; Kimberly G Blumenthal

doi:10.1093/cid/ciaa567

Penicillin Allergy Evaluation Access: A National Survey

Clin Infect Dis. 2020 Dec 31;71(11):2972-2975. doi: 10.1093/cid/ciaa567.

Authors

Christian M Mancini^{1

2}, Xiaoqing Fu^{1

2}, Yuqing Zhang^{1

2

3}, Kristi Kuper⁴, Lucas T Schulz⁵, Tanaya Bhowmick⁶, Michael Postelnick⁷, Francesca Lee⁸, Rochelle P Walensky^{2

3

9}, Kimberly G Blumenthal^{1

2

3}

Affiliations

¹ Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
² The Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Harvard Medical School, Boston, Massachusetts, USA.
⁴ Vizient, Irving, Texas, USA.
⁵ Department of Pharmacy, University of Wisconsin Health, Madison, Wisconsin, USA.
⁶ Division of Allergy, Immunology, and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
⁷ Northwestern Memorial Hospital, Department of Pharmacy, Chicago, Illinois, USA.
⁸ Department of Pathology and Internal Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
⁹ Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Abstract

In a study of 121 hospitals from 38 US states, 44% had access to an allergist for inpatient consultations and 39% had access to inpatient penicillin skin testing, indicating that the majority of US hospitals lack sufficient resources to address inpatient penicillin allergies.

Keywords: beta-lactam; hypersensitivity; skin test; testing; workforce.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / adverse effects
Drug Hypersensitivity* / diagnosis
Drug Hypersensitivity* / epidemiology
Humans
Inpatients
Penicillins* / adverse effects
Skin Tests

Substances

Anti-Bacterial Agents
Penicillins

Grants and funding

K01 AI125631/AI/NIAID NIH HHS/United States